Skip to site menu Skip to page content

Daily Newsletter

07 November 2025

Daily Newsletter

07 November 2025

Synchron secures $200m to advance Stentrode platform commercialisation

The platform is tailored to convert brain’s neural activity into digital commands, eliminating the need for open-brain surgery.

Prasanna Gullapalli November 07 2025

US-based Synchron has secured $200m in a Series D funding round to drive the commercial rollout of its Stentrode brain-computer interface (BCI) platform and aid in the creation of next-generation interfaces.

Double Point Ventures spearheaded the investment round, with support from ARCH Ventures, Bezos Expeditions, Khosla Ventures, METIS, and NTI.

New stakeholders joining this round comprise the Australian National Reconstruction Fund (NRF), Qatar Investment Authority (QIA), T.Rx Capital, K5 Global, IQT, and Protocol Labs.

Synchron also intends to use the latest funding to expedite key clinical studies and expand its team across various disciplines.

Synchron founder and CEO Tom Oxley said: “We’ve built the first non-surgical brain-computer interface designed for everyday life for people with paralysis.

“This funding brings us closer to commercialising the Stentrode BCI platform, while accelerating development of a major breakthrough in the field – a next-generation, transcatheter high-channel whole-brain interface.”

The endovascular BCI platform is tailored to convert neural activity of the brain into digital commands, eliminating the need for open-brain surgery.

It is inserted via a minimally invasive catheter procedure and interfaces with the motor cortex through blood vessels.

Without a wire involvement, the device captures neural activity and transmits the information, allowing users to interact with digital devices without physical movement.

So far, ten individuals with paralysis have received the device as part of clinical studies in Australia and the US.

Synchron incorporated Apple’s BCI-human interface device and co-developed a Bluetooth-based iOS protocol that enables direct connection of brain activity to Apple devices through Switch Control, which includes iPhone, iPad, and Vision Pro, eliminating the need for voice, touch or eye-tracking.

The company’s Cognitive AI unit in New York, US, is working on systems that interpret neurological data for real-time thought decoding.

Meanwhile, a new engineering centre in San Diego has been opened to further build advanced BIs.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close